Nanobiotix joins the Euronext Tech Leaders index

Nanobiotix, a French biotechnology company, has joined the Euronext Tech Leaders index, increasing its visibility among international investors. This index, launched by Euronext in 2022, comprises innovative, high-growth European companies. For Nanobiotix, this reflects its position at the intersection of nanotechnology, physics, and medicine, developing nanotherapeutic platforms designed to address unmet medical needs.

The company, listed on Euronext Paris and Nasdaq, sees this integration as recognition of its progress and the potential of its innovations. Nanobiotix confirms its mission to revolutionize medical treatments for millions of patients through its nanoparticle-based approach.